| Name | Title | Contact Details |
|---|
Welcome to Tyson Fresh Meats, a subsidiary of Tyson Foods, Inc., and the world`s leading supplier of premium beef and pork. Headquartered in Dakota Dunes, South Dakota, Tyson Fresh Meats maintains 17 production sites throughout North America and employs nearly 41,000 team members. At Tyson Fresh Meats, we`re strongly committed to providing our retail and foodservice customers with only the best quality and variety of fresh meat products, backed by unmatched service and support. Tyson Fresh Meats can deliver a custom-designed program and product mix that will satisfy your needs and help you achieve your business goals.
Kerry develops, manufactures and delivers innovative taste systems, functional and nutritional ingredients and integrated solutions for the Food, Beverage and Pharmaceutical markets. Customers derive maximum synergies through utilizing Kerry`s broad and deep range of food technologies, application capabilities and processing expertise.
The mission of the Del Sol Food Company is to meet and exceed the demands of our customers while producing food products of the highest quality. With integrity we will expand our company in a controlled and profitable manner, while providing courteous and professional service to all our business associates.
Bud & Marys is a multi-state, vertically integrated cannabis company that grows and sells cannabis products for both medical and lifestyle use.
Neptune is a biotechnology company engaged primarily in the development and commercialization of marine-derived omega-3 polyunsaturated fatty acids ("PUFAs"). Neptune has a patented process of extracting oils from Antarctic krill, and principally sells omega-3 PUFAs as bulk oil to Neptune`s distributors who commercialize them under their private label primarily in the U.S., European and Australian nutraceutical markets. Neptune`s products generally come in bulk oil or capsule form and serve as a dietary supplement to consumers. Neptune`s head office is located at 545 Promenade du Centropolis, Suite 100, Laval, Quebec. Neptune respectively holds approximately 49% of the participating and voting rights of Acasti and 96% of the voting rights of NeuroBio. Through these subsidiaries, Neptune is also pursuing opportunities in the medical food and prescription drug markets. Acasti and NeuroBio respectively focus on the research and development of safe and therapeutically effective compounds for highly prevalent atherosclerotic conditions, such as cardiometabolic disorders and cardiovascular diseases, and for neurodegenerative and inflammation related conditions. Acasti`s lead prescription drug candidate is CaPre(R), a purified high omega-3 phospholipid concentrate derived from Neptune krill oil being developed to address the prevention and treatment of cardiometabolic disorders, including hypertriglyceridemia, which is characterized by abnormally high levels of triglycerides.